Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Analytical approaches relating genetic evolutionary pathways to prognostic factors

A C Rohloff1, J M Sakach, S E Shackney

  • 1Medical Science Associates, Pittsburgh, Pennsylvania 15206-4490, USA.

Cytometry
|September 1, 1995
PubMed
Summary

Multiparameter flow cytometry reveals genetic abnormalities in breast cancer. Cell DNA, HER-2/neu, and ras protein content correlate with nodal status, suggesting diverse tumor evolution pathways for prognosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HER2 expression as a potential marker for response to therapy targeted to the EGFR.

British journal of cancer·2006
Same author

The analysis of relapse-free survival curves: implications for evaluating intensive systemic adjuvant treatment regimens for breast cancer.

British journal of cancer·2005
Same author

Distinctive patterns of Her-2/neu, c-myc, and cyclin D1 gene amplification by fluorescence in situ hybridization in primary human breast cancers.

Cytometry·2001
Same author

Selective estrogen receptor modulators. An aid in unraveling the links between estrogen and breast cancer.

Postgraduate medicine·2001
Same author

Multiparameter analysis of human epithelial tumor cell lines by laser scanning cytometry.

Cytometry·2001
Same author

Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas.

Clinical cancer research : an official journal of the American Association for Cancer Research·2000

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Human solid tumors accumulate genetic abnormalities during progression.
  • Understanding tumor genetic evolution is crucial for prognosis.
  • Multiparameter flow cytometry offers insights into individual tumor cell characteristics.

Purpose of the Study:

  • To analyze cell DNA, HER-2/neu, and ras protein content in primary breast cancers using multiparameter flow cytometry.
  • To correlate these measurements with clinical prognostic factors.
  • To explore genetic evolutionary pathways in individual tumors.

Main Methods:

  • Multiparameter flow cytometry was used to measure cell DNA, HER-2/neu, and ras protein content in 92 primary breast cancer patients.
  • Stepwise multiple analysis of variance (MANOVA) was employed to correlate cytometry data with clinical prognostic factors.

Related Experiment Videos

  • Nodal status was identified as a key factor in grouping patients based on cytometry parameters.

    • Main Results:

    • Ploidy, HER-2/neu, and ras protein content showed correlations with nodal status and other clinical prognostic factors.
    • Multiparameter flow cytometry data indicated multiple genetic evolutionary pathways within individual tumors.
    • MANOVA analysis also supported the existence of diverse genetic evolutionary pathways.

    Conclusions:

    • Multiparameter flow cytometry is a valuable tool for assessing genetic abnormalities in breast cancer.
    • Correlating cytometry data with clinical factors aids in understanding tumor progression.
    • Analyzing genetic evolutionary pathways offers a promising approach for defining cancer prognosis.